{"id":"W3014488763","doi":"10.1002/jha2.4","title":"Randomized, placebo‐controlled, phase 3 study of perifosine combined with bortezomib and dexamethasone in patients with relapsed, refractory multiple myeloma previously treated with bortezomib","year":2020,"lang":"en","type":"article","venue":"eJHaem","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal","funders":"","keywords":"Bortezomib; Medicine; Internal medicine; Dexamethasone; Clinical endpoint; Multiple myeloma; Placebo; Hazard ratio; Interim analysis; Adverse effect; Surgery; Gastroenterology; Oncology; Randomized controlled trial; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002826001,0.001523107,0.003615498,0.000577451,0.0006910709,0.00130465,0.0009604389,0.001858409,0.004469348],"category_scores_gemma":[0.002124387,0.0009274707,0.002002318,0.0005171213,0.001567086,0.00110149,0.0004299939,0.003206009,0.0008538915],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007691541,"about_ca_system_score_gemma":0.001632617,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007415076,"about_ca_topic_score_gemma":0.002054869,"domain_scores_codex":[0.9988316,0.0006779718,0.00006913241,0.0001945787,0.00008297457,0.0001437423],"domain_scores_gemma":[0.9985561,0.0003945166,0.000285328,0.0001284758,0.0001012321,0.0005344652],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9781166,0.01077404,0.000511663,0.0002226797,0.0005096002,0.00003339593,0.00004424284,0.0001821837,0.003064989,0.00006517624,0.0003630323,0.006112415],"study_design_scores_gemma":[0.9030304,0.09459332,0.001190432,0.00001201064,0.0001863518,0.00002054396,0.0000124187,0.0002832338,0.0002778117,0.00006841248,0.0003142485,0.00001074253],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9867731,0.002817978,0.0008735943,0.0005744633,0.0008036546,0.005982823,0.0007977984,0.0001501017,0.001226492],"genre_scores_gemma":[0.9887138,0.001138502,0.001474189,0.001025358,0.0005412464,0.005148453,0.0006391025,0.00002386111,0.001295415],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004469348,"threshold_uncertainty_score":0.01495141,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01771398157137364,"score_gpt":0.27255795567471,"score_spread":0.2548439741033364,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}